Rapid CTA

RapidAI
Information source: Public
Last updated: August 20, 2023

General Information

General
Product name Rapid CTA
Company RapidAI
Subspeciality Neuro
Modality CT
Disease targeted Stroke
Key-features
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDD
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since 03-2018
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance

  • Viz LVO versus Rapid LVO in detection of large vessel occlusion on CT angiography for acute stroke (read)

  • Machine-learning algorithm in acute stroke: real-world experience (read)

  • Positive predictive value and stroke workflow outcomes using automated vessel density (RAPID-CTA) in stroke patients: One year experience (read)
Non-peer reviewed papers on performance
Other relevant papers